Table 2 Summary of genetic testing results of the embryos from patient 2 by SGS.

From: Clinical application of nanopore sequencing for haplotype linkage analysis in preimplantation genetic testing for Duchenne muscular dystrophy

Embryo ID

Grade of

embryos

Chromosome ploidy test

Linkage analysis

E1

4BB

46, XN, del(7)(q31.1q36.3)(~ 48.14 Mb,~46%)

Carrier

E2

5CA

46, XN

Patient

E3

4BC

46, XN, −16,+21

No mutation

E4

4CB

46, XN, del(1)(q21.1q44)(~ 104.05 Mb,~67%),

dup(11)(p15.5p15.1)(~ 21.20 Mb,~50%),

del(14)(q12q21.2)(~ 19.20 Mb,~41%),

dup(14)(q21.2q32.33)(~ 62.35 Mb)

No mutation

E5

5BA

46, XN

No mutation

E6

4CB

45, X

No mutation

E7

5CB

45, XN, −8,del(9)(q21.11q22.31)(~ 23.60 Mb),

dup(16)(p13.3p11.1)(~ 35.40 Mb),

dup(20)(p13p11.1)(~ 26.00 Mb,~45%)

Uncertain

E8

5BC

46, XN

Patient

E9

5CA

46, XN, −14(~ 37%)

Patient

E10

4CB

46, XN

Patient

E11

3BC

45, XN, del(6)(q25.3q27)(~ 11.32 Mb,~39%),

−16

Carrier

E12

4CB

46, XN

No mutation